Article Versions Notes

Xu D, Li J-D, An J, Ma X-X, Wang X-L, Zhou Z, Liu H-P, Diao M-J, Jiang Y-X, Zhou L-Y, et al. A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine. Vaccines. 2024; 12(12):1356. https://doi.org/10.3390/vaccines12121356

Xu, Dan, Jia-Dai Li, Jiao An, Xin-Xing Ma, Xiao-Liang Wang, Zheng Zhou, Hai-Ping Liu, Mei-Jun Diao, Yuan-Xiang Jiang, Ling-Yun Zhou, and et al. 2024. "A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine" Vaccines 12, no. 12: 1356. https://doi.org/10.3390/vaccines12121356

Xu, D., Li, J.-D., An, J., Ma, X.-X., Wang, X.-L., Zhou, Z., Liu, H.-P., Diao, M.-J., Jiang, Y.-X., Zhou, L.-Y., Tong, X., & Zhou, C.-L. (2024). A Preclinical Immunogenicity Study of the Recombinant Human Papillomavirus Nine-Valent Virus-like Particle Vaccine. Vaccines, 12(12), 1356. https://doi.org/10.3390/vaccines12121356